generic-timeline

Whether a drug has a marketed generic today, and when its Orange Book protections lapse

Should I use this

Quality & Safety

A
Description quality
100%
Schema completeness
100%
Naming quality
80%
Poisoning risk
100%
Permission match
100%
Protocol compliance
100%

Based on automated analysis of tool definitions and protocol compliance.

Context Cost

~188Tokens (tool definitions)
~456 BTypical response size
Minimal attention impact (0.15% of 128k context)

This is the approximate number of tokens consumed each time the server's tools are loaded into a model's context. Higher counts reduce the attention available for other tasks.

Install

One-Click Install

Add this to your `claude_desktop_config.json` file:

{
  "mcpServers": {
    "generic-timeline": {
      "url": "https://rxinfo.ai/mcp"
    }
  }
}

Remote endpoints

https://rxinfo.ai/mcpstreamable-http

What it can do

Tool inventory

Tools (1)

🟢 Read-only🟡 Write🔴 Delete⚪ Unknown
⚪generic_availability_timeline(drug)

For a US prescription drug, report whether a real MARKETED generic exists today — judged on CMS NADAC price dispersion across NDCs of one drug identity, not on FDA approval counts, because an approved generic that nobody sells does not lower anyone's price. Returns the price range for the identical pill when a generic is marketed, and when one is not, the earliest expiry among listed FDA Orange Book patents and exclusivities. NEVER presents a patent expiry as a launch date. Pediatric exclusivity (21 U.S.C. 355a) is honoured, which moves some dates six months later than naive de-duplication produces.

Input Schema

{
  "type": "object",
  "properties": {
    "drug": {
      "type": "string",
      "description": "Brand or generic drug name, e.g. \"Eliquis\", \"apixaban\""
    }
  },
  "required": [
    "drug"
  ]
}

Community

Rate this Server

Evidence

Recent observations

verifiedversion not recorded1 tools
verifiedversion not recorded1 tools